Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens healthcare diagnostics has confirmed that certain samples may show human anti-mouse antibodies (hama) interference for the advia centaur hiv ag/ab combo (chiv) assay. heterophilic antibodies in human serum can react with reagent immunoglobulins interfering with in vitro immunoassays. patients routinely exposed to animals or animal serum products are prone to this interference and anomalous values may be observed. additional information may be required for diagnosis.